冠科美博（Apollomics）Uproleselan 注射液（APL-106）用于治疗复发或难治性急性髓系白血病的中国 III 期临床试验第一例受试者成功入组
Foster City, CA, Shanghai and […]...
APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia
Foster City, CA, Hangzhou, Chi […]